Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Sharon Pine

Concepts (317)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lung Neoplasms
32
2025
2668
2.880
 Why?
Carcinoma, Non-Small-Cell Lung
10
2025
1192
1.470
 Why?
Amyloid Precursor Protein Secretases
3
2018
78
1.130
 Why?
Biomarkers, Tumor
12
2025
1329
1.120
 Why?
SOX9 Transcription Factor
3
2023
27
1.090
 Why?
Leukemia, Megakaryoblastic, Acute
4
2007
10
0.800
 Why?
Receptor, Notch1
2
2014
63
0.780
 Why?
GATA1 Transcription Factor
4
2007
18
0.750
 Why?
DNA, Neoplasm
4
2010
160
0.710
 Why?
Janus Kinases
1
2021
21
0.700
 Why?
STAT Transcription Factors
1
2021
25
0.700
 Why?
Paclitaxel
2
2022
259
0.640
 Why?
Carcinoma, Squamous Cell
4
2025
641
0.620
 Why?
Signal Transduction
9
2021
5224
0.620
 Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
2005
297
0.620
 Why?
Neoplastic Stem Cells
3
2013
409
0.570
 Why?
Inflammation
4
2022
2884
0.550
 Why?
Protease Inhibitors
1
2018
102
0.530
 Why?
Benzodiazepinones
1
2017
18
0.530
 Why?
Gene Expression Regulation, Neoplastic
9
2025
1450
0.520
 Why?
Neoplasms
4
2025
2913
0.510
 Why?
Cell Line, Tumor
13
2023
3551
0.490
 Why?
Antineoplastic Agents
7
2023
2219
0.490
 Why?
Down Syndrome
4
2007
525
0.490
 Why?
F-Box Proteins
1
2016
24
0.480
 Why?
Antineoplastic Agents, Phytogenic
1
2017
178
0.480
 Why?
Oncogene Proteins, Fusion
4
2017
212
0.480
 Why?
Polymerase Chain Reaction
6
2010
1043
0.480
 Why?
Proteasome Endopeptidase Complex
1
2016
155
0.450
 Why?
Drug Resistance, Neoplasm
6
2021
883
0.440
 Why?
Interleukin-8
3
2014
269
0.430
 Why?
Ubiquitin-Protein Ligases
1
2016
194
0.430
 Why?
Neoplasms, Basal Cell
1
2013
4
0.410
 Why?
Chromosome Segregation
1
2013
45
0.400
 Why?
DNA Damage
1
2016
437
0.390
 Why?
DNA
2
2022
1437
0.360
 Why?
Cell Cycle Proteins
1
2016
630
0.360
 Why?
Interleukin-6
3
2019
780
0.360
 Why?
C-Reactive Protein
2
2011
423
0.350
 Why?
Mannose-Binding Lectin
2
2009
20
0.340
 Why?
Adenocarcinoma
3
2017
926
0.340
 Why?
Smoking
6
2024
1477
0.330
 Why?
Proto-Oncogene Proteins c-mdm2
2
2012
67
0.320
 Why?
Humans
53
2025
145783
0.320
 Why?
Case-Control Studies
14
2024
3634
0.310
 Why?
Cell Transformation, Neoplastic
2
2021
337
0.310
 Why?
Mutation
9
2023
4090
0.300
 Why?
Polymorphism, Single Nucleotide
6
2019
2181
0.290
 Why?
Mice
12
2023
18355
0.280
 Why?
Polymorphism, Genetic
2
2009
615
0.280
 Why?
Cytokines
1
2015
2069
0.270
 Why?
Inflammation Mediators
2
2021
507
0.260
 Why?
Proto-Oncogene Proteins p21(ras)
3
2023
254
0.260
 Why?
Lymphoma, AIDS-Related
1
2007
14
0.260
 Why?
Molecular Targeted Therapy
2
2021
441
0.250
 Why?
Lymphoproliferative Disorders
1
2007
59
0.250
 Why?
Leukemia
2
2007
246
0.250
 Why?
Animals
14
2023
38101
0.240
 Why?
Lymphoma, Non-Hodgkin
1
2007
124
0.230
 Why?
Nuclear Weapons
1
2025
7
0.230
 Why?
Cell Proliferation
7
2021
2514
0.230
 Why?
Base Sequence
5
2014
2171
0.220
 Why?
Neoplasms, Radiation-Induced
1
2025
100
0.210
 Why?
Female
32
2025
79045
0.210
 Why?
Carboplatin
2
2022
164
0.200
 Why?
Breast Neoplasms
2
2013
2393
0.200
 Why?
Smokers
1
2024
138
0.200
 Why?
Tumor Microenvironment
3
2023
735
0.190
 Why?
Genes, ras
1
2023
96
0.190
 Why?
Molecular Sequence Data
4
2014
2883
0.190
 Why?
Chromosomes, Human, Pair 19
1
2002
27
0.190
 Why?
Aged
19
2024
26217
0.190
 Why?
Central Nervous System Neoplasms
1
2005
177
0.180
 Why?
Alternative Splicing
1
2025
248
0.180
 Why?
Chromosomes, Human, Pair 1
1
2002
80
0.180
 Why?
Translocation, Genetic
1
2002
120
0.180
 Why?
Class I Phosphatidylinositol 3-Kinases
1
2022
108
0.180
 Why?
Intracellular Signaling Peptides and Proteins
2
2022
457
0.180
 Why?
Cell Movement
3
2020
963
0.170
 Why?
Epithelial-Mesenchymal Transition
2
2014
220
0.170
 Why?
Mechanistic Target of Rapamycin Complex 1
1
2022
138
0.170
 Why?
Pyrazines
1
2022
94
0.170
 Why?
Ribosome Subunits, Large, Eukaryotic
1
2021
2
0.170
 Why?
Immunity, Innate
1
2007
835
0.170
 Why?
Superoxide Dismutase-1
1
2021
13
0.170
 Why?
Organelle Biogenesis
1
2021
14
0.170
 Why?
Cytokinesis
1
2021
50
0.170
 Why?
Triazoles
1
2022
191
0.160
 Why?
Adenocarcinoma, Mucinous
1
2021
76
0.160
 Why?
Male
26
2025
73010
0.160
 Why?
Middle Aged
18
2024
36309
0.160
 Why?
Phosphatidylinositol 3-Kinases
1
2022
383
0.160
 Why?
Receptors, Kisspeptin-1
1
2020
2
0.160
 Why?
Proto-Oncogene Proteins c-akt
1
2022
440
0.160
 Why?
Receptor-Like Protein Tyrosine Phosphatases, Class 2
1
2019
9
0.150
 Why?
Prognosis
7
2024
4330
0.150
 Why?
Disease Susceptibility
1
2021
344
0.150
 Why?
Janus Kinase 2
1
2019
29
0.150
 Why?
Molecular Chaperones
1
2021
199
0.150
 Why?
Mice, Inbred NOD
2
2020
616
0.150
 Why?
Cellular Senescence
2
2013
226
0.150
 Why?
Cellular Reprogramming
1
2020
98
0.150
 Why?
TOR Serine-Threonine Kinases
1
2022
456
0.140
 Why?
Neoplasm, Residual
3
2005
143
0.140
 Why?
Biomarkers
2
2021
4302
0.140
 Why?
Acrylamides
1
2019
74
0.140
 Why?
Nanotechnology
1
2019
114
0.140
 Why?
Combined Modality Therapy
1
2021
1271
0.140
 Why?
Homeodomain Proteins
1
2002
523
0.140
 Why?
Immunoglobulin Heavy Chains
3
2003
86
0.140
 Why?
Aniline Compounds
1
2019
120
0.140
 Why?
Proteolysis
2
2016
172
0.140
 Why?
Carcinogenesis
1
2020
228
0.130
 Why?
Quinolines
1
2019
190
0.130
 Why?
Risk Factors
8
2015
10919
0.130
 Why?
Receptors, Notch
1
2018
90
0.130
 Why?
Transcriptome
1
2024
1042
0.130
 Why?
Quinazolines
1
2019
266
0.130
 Why?
Transfection
2
2017
927
0.130
 Why?
Tumor Suppressor Protein p53
2
2013
534
0.130
 Why?
Lung
4
2022
4116
0.130
 Why?
Disease Management
1
2021
653
0.130
 Why?
CD24 Antigen
2
2013
18
0.130
 Why?
Triple Negative Breast Neoplasms
1
2020
218
0.120
 Why?
F-Box-WD Repeat-Containing Protein 7
1
2016
6
0.120
 Why?
Neoplasm Invasiveness
2
2020
508
0.120
 Why?
Cancer Survivors
1
2022
338
0.120
 Why?
Hyaluronan Receptors
2
2013
104
0.120
 Why?
Glycogen Synthase Kinase 3 beta
1
2016
74
0.120
 Why?
Ubiquitination
1
2016
119
0.120
 Why?
Coculture Techniques
2
2013
247
0.120
 Why?
Proportional Hazards Models
2
2011
1330
0.120
 Why?
Protein Interaction Domains and Motifs
1
2016
145
0.110
 Why?
Cell Division
3
2013
757
0.110
 Why?
Proto-Oncogene Proteins B-raf
1
2017
224
0.110
 Why?
Receptors, Interleukin-8B
1
2014
29
0.110
 Why?
Cell Death
1
2016
382
0.110
 Why?
Protein Isoforms
2
2013
399
0.110
 Why?
Computational Biology
1
2019
669
0.110
 Why?
Tumor Cells, Cultured
2
2021
887
0.110
 Why?
Protein Kinase Inhibitors
2
2019
981
0.100
 Why?
Gene Expression Profiling
4
2025
1777
0.100
 Why?
3' Untranslated Regions
1
2014
149
0.100
 Why?
Patient Selection
1
2018
739
0.100
 Why?
Software
1
2019
680
0.100
 Why?
Disease Progression
1
2021
2865
0.100
 Why?
Energy Metabolism
1
2020
935
0.100
 Why?
Ultraviolet Rays
1
2016
385
0.100
 Why?
Platinum Compounds
1
2013
10
0.100
 Why?
Genes, T-Cell Receptor
2
2003
6
0.100
 Why?
Colorectal Neoplasms
1
2021
868
0.100
 Why?
Research Design
2
2011
1139
0.100
 Why?
Dipeptides
1
2013
56
0.100
 Why?
Core Binding Factor Alpha 2 Subunit
2
2003
31
0.090
 Why?
Models, Biological
2
2019
1764
0.090
 Why?
Gene Expression Regulation
1
2021
2601
0.090
 Why?
Alleles
3
2014
896
0.090
 Why?
Lymphocytes, Tumor-Infiltrating
1
2013
154
0.090
 Why?
Survival Analysis
2
2013
1378
0.090
 Why?
Stromal Cells
1
2012
121
0.090
 Why?
Phosphorylation
1
2016
1708
0.090
 Why?
Gap Junctions
1
2012
67
0.090
 Why?
Genotype
4
2014
1857
0.090
 Why?
HIV Infections
1
2007
3195
0.080
 Why?
National Cancer Institute (U.S.)
1
2011
54
0.080
 Why?
Bone Marrow Cells
1
2012
322
0.080
 Why?
Infant
4
2007
10091
0.080
 Why?
Risk Assessment
3
2011
3752
0.080
 Why?
Japan
2
2025
149
0.080
 Why?
Cell Communication
1
2012
327
0.080
 Why?
Melanoma
1
2017
762
0.080
 Why?
Protein Binding
1
2016
2240
0.080
 Why?
ROC Curve
2
2024
618
0.080
 Why?
AC133 Antigen
1
2010
20
0.080
 Why?
Bromodeoxyuridine
1
2010
77
0.080
 Why?
Adult
8
2020
40881
0.080
 Why?
Phenotype
3
2013
3170
0.080
 Why?
Biopsy
2
2017
1082
0.070
 Why?
Logistic Models
2
2011
2139
0.070
 Why?
Exons
2
2008
364
0.070
 Why?
DNA Replication
1
2010
249
0.070
 Why?
Glycoproteins
1
2010
354
0.070
 Why?
Genetic Predisposition to Disease
4
2012
2399
0.070
 Why?
Cell Differentiation
2
2008
2050
0.070
 Why?
Polymorphism, Single-Stranded Conformational
1
2007
26
0.070
 Why?
Baltimore
1
2007
72
0.060
 Why?
CD8-Positive T-Lymphocytes
1
2013
923
0.060
 Why?
Tobacco Smoke Pollution
1
2009
227
0.060
 Why?
Smoking Cessation
1
2011
441
0.060
 Why?
Sequence Homology, Nucleic Acid
1
2007
157
0.060
 Why?
Linkage Disequilibrium
1
2007
255
0.060
 Why?
Prospective Studies
2
2011
8078
0.060
 Why?
Antigens, CD
1
2010
558
0.060
 Why?
Autophagy
2
2023
291
0.060
 Why?
DNA Primers
2
2008
505
0.060
 Why?
Superoxide Dismutase
1
2008
308
0.060
 Why?
ErbB Receptors
2
2019
635
0.060
 Why?
Infant, Newborn
3
2007
6465
0.060
 Why?
Neoplasm Staging
3
2017
1475
0.060
 Why?
In Situ Hybridization, Fluorescence
1
2007
328
0.060
 Why?
Haplotypes
1
2007
500
0.060
 Why?
Predictive Value of Tests
1
2011
2123
0.060
 Why?
Disease-Free Survival
1
2007
770
0.060
 Why?
Chromosomes, Human, Pair 21
1
2005
43
0.060
 Why?
Gene Knockdown Techniques
2
2021
334
0.060
 Why?
Preservation, Biological
1
2005
7
0.060
 Why?
Remission Induction
1
2005
306
0.050
 Why?
Liquid Biopsy
1
2024
15
0.050
 Why?
MicroRNAs
3
2019
686
0.050
 Why?
Cloning, Molecular
1
2005
538
0.050
 Why?
United States
3
2020
16126
0.050
 Why?
History, 21st Century
1
2025
222
0.050
 Why?
Child
5
2009
22740
0.050
 Why?
Tobacco Smoking
1
2024
27
0.050
 Why?
Child, Preschool
3
2005
11868
0.050
 Why?
History, 20th Century
1
2025
328
0.050
 Why?
Mice, Knockout
2
2021
3130
0.050
 Why?
Peptides
1
2010
999
0.050
 Why?
Chronology as Topic
1
2003
2
0.050
 Why?
Chromosome Breakage
1
2003
23
0.050
 Why?
Reproducibility of Results
2
2019
3418
0.050
 Why?
Artificial Gene Fusion
1
2002
3
0.050
 Why?
Restriction Mapping
1
2002
81
0.050
 Why?
Gene Expression
1
2008
1478
0.050
 Why?
Mitogen-Activated Protein Kinase Kinases
1
2023
126
0.050
 Why?
Clone Cells
1
2003
263
0.050
 Why?
Mucins
1
2022
75
0.040
 Why?
Apoptosis
2
2021
2444
0.040
 Why?
Gene Rearrangement
1
2002
156
0.040
 Why?
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
2003
89
0.040
 Why?
Immunophenotyping
1
2003
322
0.040
 Why?
Promoter Regions, Genetic
1
2006
1247
0.040
 Why?
Chromosome Mapping
1
2002
507
0.040
 Why?
Cell Nucleolus
1
2021
20
0.040
 Why?
Adenosine
1
2022
255
0.040
 Why?
RNA Processing, Post-Transcriptional
1
2021
90
0.040
 Why?
Down-Regulation
1
2022
618
0.040
 Why?
Mutagenesis, Site-Directed
1
2021
376
0.040
 Why?
Aftercare
1
2022
222
0.040
 Why?
Glutaminase
1
2020
11
0.040
 Why?
Time Factors
1
2011
7134
0.040
 Why?
Fibrosis
1
2022
561
0.040
 Why?
Precision Medicine
1
2024
461
0.040
 Why?
RNA Precursors
1
2021
154
0.040
 Why?
Africa, Western
1
2019
21
0.040
 Why?
Mice, Nude
1
2021
680
0.040
 Why?
A549 Cells
1
2019
75
0.040
 Why?
Tumor Stem Cell Assay
1
2019
34
0.040
 Why?
Glutamine
1
2020
109
0.040
 Why?
Recurrence
1
2003
1139
0.040
 Why?
Exome
1
2020
229
0.040
 Why?
Nucleotides
1
2020
129
0.040
 Why?
Mice, SCID
1
2020
369
0.040
 Why?
Receptors, Antigen, T-Cell
1
2002
673
0.040
 Why?
Killer Cells, Natural
1
2022
481
0.040
 Why?
DNA Mutational Analysis
1
2019
410
0.040
 Why?
Tumor Burden
1
2020
325
0.030
 Why?
Incidence
2
2019
2934
0.030
 Why?
Proto-Oncogene Proteins c-myc
1
2020
169
0.030
 Why?
Survivors
1
2022
523
0.030
 Why?
Xenograft Model Antitumor Assays
1
2021
936
0.030
 Why?
STAT3 Transcription Factor
1
2019
206
0.030
 Why?
Cell Nucleus
1
2021
588
0.030
 Why?
Genetic Therapy
1
2019
316
0.030
 Why?
DNA-Binding Proteins
1
2005
1482
0.030
 Why?
B-Lymphocytes
1
2003
872
0.030
 Why?
Immunotherapy
1
2022
668
0.030
 Why?
Risk
1
2019
923
0.030
 Why?
Young Adult
3
2020
14254
0.030
 Why?
Transcription Factors
1
2005
1736
0.030
 Why?
Health Status Disparities
1
2019
321
0.030
 Why?
Positron Emission Tomography Computed Tomography
1
2017
118
0.030
 Why?
Adolescent
3
2009
22577
0.030
 Why?
Follow-Up Studies
2
2019
5428
0.030
 Why?
Pyrimidines
1
2019
530
0.030
 Why?
Indoles
1
2019
507
0.030
 Why?
MAP Kinase Signaling System
1
2017
308
0.030
 Why?
Neoplasm Metastasis
1
2017
688
0.030
 Why?
Survival Rate
1
2019
2094
0.030
 Why?
Leupeptins
1
2013
13
0.030
 Why?
Cell Survival
1
2017
1104
0.030
 Why?
Macrolides
1
2013
67
0.020
 Why?
Transduction, Genetic
1
2013
132
0.020
 Why?
Octamer Transcription Factor-3
1
2012
19
0.020
 Why?
Ligands
1
2014
668
0.020
 Why?
Binding Sites
1
2014
1311
0.020
 Why?
Neoplasm Proteins
1
2013
442
0.020
 Why?
Cohort Studies
2
2012
6033
0.020
 Why?
Disease Models, Animal
1
2021
4568
0.020
 Why?
Recombinant Proteins
1
2013
1368
0.020
 Why?
Mice, Inbred C57BL
1
2021
5992
0.020
 Why?
Cross-Sectional Studies
1
2022
5925
0.020
 Why?
Genetic Variation
1
2014
977
0.020
 Why?
Confidence Intervals
1
2010
330
0.020
 Why?
Age Distribution
1
2010
404
0.020
 Why?
Early Detection of Cancer
1
2014
486
0.020
 Why?
Sex Distribution
1
2010
388
0.020
 Why?
Treatment Outcome
1
2024
11794
0.020
 Why?
Small Cell Lung Carcinoma
1
2010
123
0.020
 Why?
Reference Values
1
2010
798
0.020
 Why?
Enzyme Stability
1
2008
73
0.020
 Why?
Homozygote
1
2008
199
0.020
 Why?
Neoplasm Recurrence, Local
1
2014
1150
0.020
 Why?
Linear Models
1
2010
849
0.020
 Why?
Odds Ratio
1
2010
1083
0.020
 Why?
Amino Acid Substitution
1
2008
302
0.020
 Why?
Colonic Neoplasms
1
2009
258
0.020
 Why?
Aged, 80 and over
1
2019
8347
0.010
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2008
979
0.010
 Why?
Cells, Cultured
1
2013
4151
0.010
 Why?
Erythroid-Specific DNA-Binding Factors
1
2005
17
0.010
 Why?
Comorbidity
1
2010
1662
0.010
 Why?
Environmental Exposure
1
2009
578
0.010
 Why?
Aneuploidy
1
2005
91
0.010
 Why?
Genome-Wide Association Study
1
2010
1430
0.010
 Why?
Retrospective Studies
1
2014
17330
0.010
 Why?
Antineoplastic Combined Chemotherapy Protocols
1
2005
1969
0.010
 Why?
Pine's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (317) concept(s)
_
Co-Authors Expand Description
See all (9) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)